Figure 1.
Schematic representation of different molecular targets of cannabidiol (CBD) and their involvement on the mechanisms of hypoxic-ischemic brain injury (HIBI). Dot-lined boxes indicate which ones have been studied in preclinical models of neonatal HIBI.